A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)

NCT00071812 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

283

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Placebo
DRUG: Belimumab 1 mg/kg
DRUG: Belimumab 4 mg/kg
DRUG: Belimumab 10 mg/kg

Sponsor

Human Genome Sciences Inc.